Synevo Studien Service Labor GmbH is part of Synevo Central Labs - the largest, harmonized and GCLP-certified network of central laboratories in Europe with facilities in Germany, Poland, Romania, Ukraine, Belarus, Bulgaria, Serbia, Moldova, Georgia, Turkey and Russia.
As a central laboratory for clinical trials, we specialize in laboratory analyses for clinical trials and research projects. For more than 10 years, we have been offering our full service for monocentric and multicentric clinical trials in the national and international environment. Our customers include pharmaceutical and biotechnological companies, CROs, clinics and university institutions.
Our team in Berlin is specialized in offering customized laboratory analysis for the successful implementation of your project. Our constantly growing portfolio currently consists of more than 3000 analyses and includes, in addition to the classical safety and routine parameters, biomarkers for advanced diagnostics. On request, we can develop and validate analyses specifically for clinical trials based on the customer needs. Our laboratory analysis is subject to strictest quality controls.
In order to guarantee the highest quality of your study data, we provide scientific advice from the planning stage through the entire duration of the project and offer comprehensive analytical services. This includes the provision of study-specific laboratory kits for specimen collection, the laboratory manual, the organization of sample shipment, analytics and data transfer according to study-specific requirements.
We offer our customers access to their study data in real-time via an in-house developed web-based, secure and user-friendly database: LabOne. The database enables the monitoring of trial progress as well as the creation of trend analyses and customer-specific reports.
By harmonizing the laboratory services in our network, we can offer cost- and time-efficient solutions. Comparable laboratory results are generated by local laboratories and transmitted into a single global database. Thus, logistics costs are reduced to a minimum and laboratory data are immediately available to investigators and sponsors.